| Mr David Michael Boudreaux, CRNA | |
|
902 N Hennessey St, New Orleans, LA 70119-3622 | |
| (504) 488-1409 | |
| (504) 483-3277 |
| Full Name | Mr David Michael Boudreaux |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 902 N Hennessey St, New Orleans, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063494722 | NPI | - | NPPES |
| 199945001 | Medicaid | TX | |
| 001751800 | Medicaid | FL | |
| 1901741 | Medicaid | LA | |
| P00731625 | Other | TX | RAILROAD MEDICARE |
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
Bolder BioTechnology, Inc. today announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant totaling $600,000 from the National Institute of Allergy and Infectious Diseases (NIAID) of The National Institutes of Health (NIH). The grant will be used to demonstrate the feasibility of using our novel, long-acting IL-11 analog to accelerate platelet recovery and improve survival in a mouse model of Acute Radiation Syndrome (ARS).
"The tragic murders of nine anti-polio workers in Pakistan last month, followed by the New Year's Day killing of seven more local community development workers, was both a wake-up call to the global polio eradication effort in its current form, and a 'canary in the mine' regarding the deteriorating state of development and security in the country," Heidi Larson, a senior lecturer and principal investigator at the London School of Hygiene & Tropical Medicine, writes in a SciDev.Net opinion piece.
The current special issue of Technology and Innovation, is devoted to patents that benefit people around the world who live with limited resources, in challenging environments, and are in need of better access to basic needs and improved standards of living, health and infrastructure.
A breakthrough non-invasive test can detect whether transplanted kidneys are in the process of being rejected, as well as identify patients at risk for rejection weeks to months before they show symptoms, according to a study published in The New England Journal of Medicine (NEJM).
Chronic pain patients with a history of depression are three times more likely to receive long-term prescriptions for opioid medications like Vicodin compared to pain patients who do not suffer from depression, according to new research.
› Verified 3 days ago
| Entity Name | Administrators Of The Tulane Educational Fund |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528014164 PECOS PAC ID: 0446163760 Enrollment ID: O20031201000636 |
News Archive
Bolder BioTechnology, Inc. today announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant totaling $600,000 from the National Institute of Allergy and Infectious Diseases (NIAID) of The National Institutes of Health (NIH). The grant will be used to demonstrate the feasibility of using our novel, long-acting IL-11 analog to accelerate platelet recovery and improve survival in a mouse model of Acute Radiation Syndrome (ARS).
"The tragic murders of nine anti-polio workers in Pakistan last month, followed by the New Year's Day killing of seven more local community development workers, was both a wake-up call to the global polio eradication effort in its current form, and a 'canary in the mine' regarding the deteriorating state of development and security in the country," Heidi Larson, a senior lecturer and principal investigator at the London School of Hygiene & Tropical Medicine, writes in a SciDev.Net opinion piece.
The current special issue of Technology and Innovation, is devoted to patents that benefit people around the world who live with limited resources, in challenging environments, and are in need of better access to basic needs and improved standards of living, health and infrastructure.
A breakthrough non-invasive test can detect whether transplanted kidneys are in the process of being rejected, as well as identify patients at risk for rejection weeks to months before they show symptoms, according to a study published in The New England Journal of Medicine (NEJM).
Chronic pain patients with a history of depression are three times more likely to receive long-term prescriptions for opioid medications like Vicodin compared to pain patients who do not suffer from depression, according to new research.
› Verified 3 days ago
| Entity Name | Mid-louisiana Anesthesia Consultants, Apmc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205888914 PECOS PAC ID: 3971408733 Enrollment ID: O20031204000583 |
News Archive
Bolder BioTechnology, Inc. today announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant totaling $600,000 from the National Institute of Allergy and Infectious Diseases (NIAID) of The National Institutes of Health (NIH). The grant will be used to demonstrate the feasibility of using our novel, long-acting IL-11 analog to accelerate platelet recovery and improve survival in a mouse model of Acute Radiation Syndrome (ARS).
"The tragic murders of nine anti-polio workers in Pakistan last month, followed by the New Year's Day killing of seven more local community development workers, was both a wake-up call to the global polio eradication effort in its current form, and a 'canary in the mine' regarding the deteriorating state of development and security in the country," Heidi Larson, a senior lecturer and principal investigator at the London School of Hygiene & Tropical Medicine, writes in a SciDev.Net opinion piece.
The current special issue of Technology and Innovation, is devoted to patents that benefit people around the world who live with limited resources, in challenging environments, and are in need of better access to basic needs and improved standards of living, health and infrastructure.
A breakthrough non-invasive test can detect whether transplanted kidneys are in the process of being rejected, as well as identify patients at risk for rejection weeks to months before they show symptoms, according to a study published in The New England Journal of Medicine (NEJM).
Chronic pain patients with a history of depression are three times more likely to receive long-term prescriptions for opioid medications like Vicodin compared to pain patients who do not suffer from depression, according to new research.
› Verified 3 days ago
| Entity Name | Childrens Hospital Anesthesia Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649362740 PECOS PAC ID: 0446152862 Enrollment ID: O20040124000258 |
News Archive
Bolder BioTechnology, Inc. today announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant totaling $600,000 from the National Institute of Allergy and Infectious Diseases (NIAID) of The National Institutes of Health (NIH). The grant will be used to demonstrate the feasibility of using our novel, long-acting IL-11 analog to accelerate platelet recovery and improve survival in a mouse model of Acute Radiation Syndrome (ARS).
"The tragic murders of nine anti-polio workers in Pakistan last month, followed by the New Year's Day killing of seven more local community development workers, was both a wake-up call to the global polio eradication effort in its current form, and a 'canary in the mine' regarding the deteriorating state of development and security in the country," Heidi Larson, a senior lecturer and principal investigator at the London School of Hygiene & Tropical Medicine, writes in a SciDev.Net opinion piece.
The current special issue of Technology and Innovation, is devoted to patents that benefit people around the world who live with limited resources, in challenging environments, and are in need of better access to basic needs and improved standards of living, health and infrastructure.
A breakthrough non-invasive test can detect whether transplanted kidneys are in the process of being rejected, as well as identify patients at risk for rejection weeks to months before they show symptoms, according to a study published in The New England Journal of Medicine (NEJM).
Chronic pain patients with a history of depression are three times more likely to receive long-term prescriptions for opioid medications like Vicodin compared to pain patients who do not suffer from depression, according to new research.
› Verified 3 days ago
| Entity Name | Parish Anesthesia Of Jefferson, L.l.c |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508054560 PECOS PAC ID: 6608965975 Enrollment ID: O20071210000390 |
News Archive
Bolder BioTechnology, Inc. today announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant totaling $600,000 from the National Institute of Allergy and Infectious Diseases (NIAID) of The National Institutes of Health (NIH). The grant will be used to demonstrate the feasibility of using our novel, long-acting IL-11 analog to accelerate platelet recovery and improve survival in a mouse model of Acute Radiation Syndrome (ARS).
"The tragic murders of nine anti-polio workers in Pakistan last month, followed by the New Year's Day killing of seven more local community development workers, was both a wake-up call to the global polio eradication effort in its current form, and a 'canary in the mine' regarding the deteriorating state of development and security in the country," Heidi Larson, a senior lecturer and principal investigator at the London School of Hygiene & Tropical Medicine, writes in a SciDev.Net opinion piece.
The current special issue of Technology and Innovation, is devoted to patents that benefit people around the world who live with limited resources, in challenging environments, and are in need of better access to basic needs and improved standards of living, health and infrastructure.
A breakthrough non-invasive test can detect whether transplanted kidneys are in the process of being rejected, as well as identify patients at risk for rejection weeks to months before they show symptoms, according to a study published in The New England Journal of Medicine (NEJM).
Chronic pain patients with a history of depression are three times more likely to receive long-term prescriptions for opioid medications like Vicodin compared to pain patients who do not suffer from depression, according to new research.
› Verified 3 days ago
| Entity Name | Parish Anesthesia Of Tulane |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588998231 PECOS PAC ID: 5496897753 Enrollment ID: O20100125000469 |
News Archive
Bolder BioTechnology, Inc. today announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant totaling $600,000 from the National Institute of Allergy and Infectious Diseases (NIAID) of The National Institutes of Health (NIH). The grant will be used to demonstrate the feasibility of using our novel, long-acting IL-11 analog to accelerate platelet recovery and improve survival in a mouse model of Acute Radiation Syndrome (ARS).
"The tragic murders of nine anti-polio workers in Pakistan last month, followed by the New Year's Day killing of seven more local community development workers, was both a wake-up call to the global polio eradication effort in its current form, and a 'canary in the mine' regarding the deteriorating state of development and security in the country," Heidi Larson, a senior lecturer and principal investigator at the London School of Hygiene & Tropical Medicine, writes in a SciDev.Net opinion piece.
The current special issue of Technology and Innovation, is devoted to patents that benefit people around the world who live with limited resources, in challenging environments, and are in need of better access to basic needs and improved standards of living, health and infrastructure.
A breakthrough non-invasive test can detect whether transplanted kidneys are in the process of being rejected, as well as identify patients at risk for rejection weeks to months before they show symptoms, according to a study published in The New England Journal of Medicine (NEJM).
Chronic pain patients with a history of depression are three times more likely to receive long-term prescriptions for opioid medications like Vicodin compared to pain patients who do not suffer from depression, according to new research.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr David Michael Boudreaux, CRNA 902 N Hennessey St, New Orleans, LA 70119-3622 Ph: (504) 488-1409 | Mr David Michael Boudreaux, CRNA 902 N Hennessey St, New Orleans, LA 70119-3622 Ph: (504) 488-1409 |
News Archive
Bolder BioTechnology, Inc. today announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant totaling $600,000 from the National Institute of Allergy and Infectious Diseases (NIAID) of The National Institutes of Health (NIH). The grant will be used to demonstrate the feasibility of using our novel, long-acting IL-11 analog to accelerate platelet recovery and improve survival in a mouse model of Acute Radiation Syndrome (ARS).
"The tragic murders of nine anti-polio workers in Pakistan last month, followed by the New Year's Day killing of seven more local community development workers, was both a wake-up call to the global polio eradication effort in its current form, and a 'canary in the mine' regarding the deteriorating state of development and security in the country," Heidi Larson, a senior lecturer and principal investigator at the London School of Hygiene & Tropical Medicine, writes in a SciDev.Net opinion piece.
The current special issue of Technology and Innovation, is devoted to patents that benefit people around the world who live with limited resources, in challenging environments, and are in need of better access to basic needs and improved standards of living, health and infrastructure.
A breakthrough non-invasive test can detect whether transplanted kidneys are in the process of being rejected, as well as identify patients at risk for rejection weeks to months before they show symptoms, according to a study published in The New England Journal of Medicine (NEJM).
Chronic pain patients with a history of depression are three times more likely to receive long-term prescriptions for opioid medications like Vicodin compared to pain patients who do not suffer from depression, according to new research.
› Verified 3 days ago
Wendy Lynn Cambre, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-3755 | |
Lyndsey Launa Martin, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-3755 | |
Harold Stevenon Mustin Iii, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2021 Perdido St, New Orleans, LA 70112 Phone: 504-903-3370 Fax: 504-897-7008 | |
Lisa Battley, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-4000 | |
Paige Crespo, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-4000 | |
Stephen Michael Kelly, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2021 Perdido St, New Orleans, LA 70112 Phone: 504-903-3370 | |
Ashlee Babst, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2021 Perdido St, New Orleans, LA 70112 Phone: 504-875-9750 |